Balaxi Pharmaceuticals Limited(IN:BALAXI)
₹31.65+5.18 (+19.57%)
IN:BALAXI
Balaxi Pharmaceuticals Limited Revenue
₹31.65
At close:+5.18 (+19.57%)
Want to see IN:BALAXI full AI Analyst Report?
Balaxi Pharmaceuticals Limited (BALAXI) Revenue
0 Followers
Balaxi Pharmaceuticals Limited Revenue
Balaxi Pharmaceuticals Limited had a revenue of 736.31M in the quarter ending Mar 31, 2026, with 1.50%. This bring the company's revenue in the last twelve months to 2.73B, Decreased 0.96%. In the fiscal year ending Mar 31, 2026, Balaxi Pharmaceuticals Limited had annual revenue of 2.73B with -5.49% growth.
- Revenue (ttm)
- 2.73B
- Revenue Growth
- ―
- P/S Ratio
- 0.64
- Revenue/Employee
- INR 5,459,894
- Employees
- 500
- Market Cap
- INR 1.75B
Revenue Chart
Balaxi Pharmaceuticals Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.73B | -158.50M | -5.49% |
| Mar 31, 2025 | 2.89B | 475.50M | 19.71% |
| Mar 31, 2024 | 2.41B | -951.38M | -28.28% |
| Mar 31, 2023 | 3.36B | 570.45M | 20.42% |
| Mar 31, 2022 | 2.79B | 480.55M | 20.77% |
| Mar 31, 2021 | 2.31B | 1.86B | 406.95% |
| Mar 31, 2020 | 456.32M | 320.37M | 235.65% |
| Mar 31, 2019 | 135.95M | 135.95M | -27190920.00% |
| Mar 31, 2018 | -500.00 | 6.14M | -99.99% |
| Mar 31, 2017 | -6.14M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:BALAXI | 2.73B |
| IN:ALPA | 1.16B |
| IN:BALPHARMA | 3.34B |
| IN:PAR | 1.08B |
| IN:NATCAPSUQ | 857.19M |
| IN:BI | ― |

